Tonix Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,998 | $2,429 | $2,582 | $2,822 |
Gross Profit | -1,274 | 1,486 | 1,399 | 1,267 |
EBITDA | -28,296 | -16,054 | -21,612 | -15,044 |
EBIT | -16,547 | -22,108 | -15,554 | |
Net Income | -28,272 | -16,829 | -22,108 | -14,213 |
Net Change In Cash | 1,998 | 2,429 | 2,582 | 2,822 |
Free Cash Flow | -15,360 | -16,585 | -14,633 | -18,810 |
Cash | 125,331 | 131,716 | 98,776 | 28,233 |
Basic Shares | 7,327 | 5,927 | 2,263 | 6,212 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,094 | $7,768 | $9,027 | $0 |
Gross Profit | 2,329 | 3,027 | -112,091 | -92,312 |
EBITDA | -126,615 | -114,089 | -110,838 | -92,262 |
EBIT | -130,036 | -118,380 | -112,091 | -92,312 |
Net Income | -130,036 | -116,658 | -115,004 | -92,212 |
Net Change In Cash | 10,094 | 7,768 | 9,027 | 0 |
Cost of Revenue | 101,623 | |||
Free Cash Flow | -61,045 | -109,898 | -146,200 | -110,864 |
Cash | 98,776 | 24,948 | 120,229 | 178,660 |
Basic Shares | 2,263 | 1,831 | 3,068 | 7,050 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$3.86 |
2025-03-31 | -$2.64 |
2024-12-31 | -$9.76 |
